Multiple Sclerosis and Related Disorders

Managing pediatric MS in the current era 1:46
Managing pediatric MS in the current era
Tanuja Chitnis • 26 Apr 2021
Early predictors of long-term disability in pediatric MS 4:46
Early predictors of long-term disability in pediatric MS
Ermelinda de Meo • 23 Apr 2021
Predictive and prognostic biomarkers for pediatric MOGAD and NMOSD 3:04
Predictive and prognostic biomarkers for pediatric MOGAD and NMOSD
Brenda Banwell • 26 Apr 2021
Population-based studies are needed for patients with MS & COVID-19 1:29
Population-based studies are needed for patients with MS & COVID-19
Afagh Garjani • 26 Apr 2021
Update on pediatric NMOSD and MOGAD 3:47
Update on pediatric NMOSD and MOGAD
Brenda Banwell • 26 Apr 2021
The impact of COVID-19 in the UK MS Register COVID-19 prospective cohort study 5:36
The impact of COVID-19 in the UK MS Register COVID-19 prospective cohort study
Afagh Garjani • 26 Apr 2021
Identifying cognitive phenotypes in multiple sclerosis 3:47
Identifying cognitive phenotypes in multiple sclerosis
Ermelinda de Meo • 23 Apr 2021
Progress in the multiple sclerosis field: progressive MS 2:02
Progress in the multiple sclerosis field: progressive MS
Ermelinda de Meo • 23 Apr 2021
COVID-19 & MS at AAN 2021 2:15
COVID-19 & MS at AAN 2021
Afagh Garjani • 26 Apr 2021
Hypersomnia management in MS and Parkinson’s disease 2:18
Hypersomnia management in MS and Parkinson’s disease
Chantale Branson • 7 Apr 2021
DMTs and risk for severe COVID-19 in multiple sclerosis patients 2:51
DMTs and risk for severe COVID-19 in multiple sclerosis patients
Maria Pia Sormani • 6 Apr 2021
Tolebrutinib reduces new MRI lesions in highly active relapsing MS 2:28
Tolebrutinib reduces new MRI lesions in highly active relapsing MS
Anthony Traboulsee • 9 Apr 2021
Phase III trials of tolebrutinib in relapsing-remitting and progressive MS 2:20
Phase III trials of tolebrutinib in relapsing-remitting and progressive MS
Anthony Traboulsee • 9 Apr 2021
The impact of a healthy lifestyle in multiple sclerosis 2:11
The impact of a healthy lifestyle in multiple sclerosis
Vijayshree Yadav • 17 Apr 2021
Vascular disease risk factors in multiple sclerosis patients 3:01
Vascular disease risk factors in multiple sclerosis patients
Vijayshree Yadav • 17 Apr 2021
Advances in MS research 1:45
Advances in MS research
Vijayshree Yadav • 17 Apr 2021
The content of VJNeurology is intended for healthcare professionals